Search results
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
Zacks via Yahoo Finance· 2 days agoJNJ, Novo Nordisk NVO, Merck, AbbVie, Novartis and Eli Lilly andCompany LLY, among others. Of these,...
Meet the millionaires next door. These Americans made millions out of nothing.
USA TODAY via Yahoo Finance· 2 hours agoMaking millions of dollars with a fleet of ice cream trucks, or an eBay business, or a family...
Skincare Company Galderma Sees Opportunity in ‘Ozempic Face’
The Wall Street Journal· 20 hours agoSpeedy weight loss from drugs used to fight obesity and diabetes has left some users looking gaunt...
Appeals court finds 'Obamacare' pillar unconstitutional in suit over HIV-prevention drug
NBC News via Yahoo News· 12 hours agoIn particular, Gilead’s lenacapavir, given via injection twice yearly, could gain approval for use...
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Reuters· 13 hours agoAmylyx Pharmaceuticals has agreed to buy the rights to bankrupt drugmaker Eiger BioPharmaceuticals'...
Weight Loss Drugs Are Poised to Cost New York City Retail, According to Study
WWD· 21 hours agoAccording to Impact Analytics’ new research, New York is leading in GLP-1 drug usage, with a...
Nicotine-pouch giant Zyn halts online sales in the face of controversy
The Independent via Yahoo News· 17 hours agoZyn products have been a point of controversy for months. In January, Senate...Chuck Schumer called...
More Than 100 Canned Coffee Brands Recalled Due to Botulism Risk
Eating Well via Yahoo News· 17 hours agoThere are over 250 coffees on this list—check your pantry and refrigerator stat! Getty Images The...
Zealand Pharma says weight loss drug could be comparable to GLP1-RAs
Clinical Trials Arena via Yahoo Finance· 21 hours agoThe Danish biotech company has shared data showing that its investigational weight loss drug...
Jazz Pharmaceuticals' tremor drug fails in mid-stage study
Reuters via Yahoo News· 2 days ago(Reuters) -Jazz Pharmaceuticals said on Thursday its experimental drug to treat a common movement disorder failed to reduce tremor severity in a mid-stage study, sending the ...